Considering personalized interferon beta therapy for COVID-19

Karim Dorgham; Avidan U. Neumann; Maxens Decavele; Charles Edouard Luyt; Hans Yssel; Guy Gorochov

doi:10.1128/AAC.00065-21

Considering personalized interferon beta therapy for COVID-19

Karim Dorgham
, Avidan U. Neumann
, Maxens Decavele
, Charles Edouard Luyt
, Hans Yssel
, Guy Gorochov

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English
Article number	e00065-21
Journal	Antimicrobial Agents and Chemotherapy
Volume	65
Issue number	4
DOIs	https://doi.org/10.1128/AAC.00065-21
State	Published - 18 Mar 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Biotherapy
COVID-19
Interferon beta

Access to Document

10.1128/AAC.00065-21

Cite this

@article{9172ffea640940af810f0cfdf0e8ce4a,

title = "Considering personalized interferon beta therapy for COVID-19",

keywords = "Biotherapy, COVID-19, Interferon beta",

author = "Karim Dorgham and Neumann, \{Avidan U.\} and Maxens Decavele and Luyt, \{Charles Edouard\} and Hans Yssel and Guy Gorochov",

year = "2021",

month = mar,

day = "18",

doi = "10.1128/AAC.00065-21",

language = "אנגלית",

volume = "65",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - Considering personalized interferon beta therapy for COVID-19

AU - Dorgham, Karim

AU - Neumann, Avidan U.

AU - Decavele, Maxens

AU - Luyt, Charles Edouard

AU - Yssel, Hans

AU - Gorochov, Guy

PY - 2021/3/18

Y1 - 2021/3/18

KW - Biotherapy

KW - COVID-19

KW - Interferon beta

UR - https://www.scopus.com/pages/publications/85103013500

U2 - 10.1128/AAC.00065-21

DO - 10.1128/AAC.00065-21

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 33558300

AN - SCOPUS:85103013500

SN - 0066-4804

VL - 65

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 4

M1 - e00065-21

ER -

Considering personalized interferon beta therapy for COVID-19

UN SDGs

Keywords

Access to Document

Other files and links

Cite this